509 related articles for article (PubMed ID: 22902482)
1. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques.
Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N
Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
3. Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing.
Genina N; Fors D; Palo M; Peltonen J; Sandler N
Int J Pharm; 2013 Sep; 453(2):488-97. PubMed ID: 23769992
[TBL] [Abstract][Full Text] [Related]
4. Application of a colorimetric technique in quality control for printed pediatric orodispersible drug delivery systems containing propranolol hydrochloride.
Vakili H; Nyman JO; Genina N; Preis M; Sandler N
Int J Pharm; 2016 Sep; 511(1):606-618. PubMed ID: 27444550
[TBL] [Abstract][Full Text] [Related]
5. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
[TBL] [Abstract][Full Text] [Related]
6. Development of Oromucosal Dosage Forms by Combining Electrospinning and Inkjet Printing.
Palo M; Kogermann K; Laidmäe I; Meos A; Preis M; Heinämäki J; Sandler N
Mol Pharm; 2017 Mar; 14(3):808-820. PubMed ID: 28195483
[TBL] [Abstract][Full Text] [Related]
7. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
8. QR encoded smart oral dosage forms by inkjet printing.
Edinger M; Bar-Shalom D; Sandler N; Rantanen J; Genina N
Int J Pharm; 2018 Jan; 536(1):138-145. PubMed ID: 29183858
[TBL] [Abstract][Full Text] [Related]
9. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
10. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms.
Vakili H; Kolakovic R; Genina N; Marmion M; Salo H; Ihalainen P; Peltonen J; Sandler N
Int J Pharm; 2015 Apr; 483(1-2):244-9. PubMed ID: 25527212
[TBL] [Abstract][Full Text] [Related]
11. Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.
Iftimi LD; Edinger M; Bar-Shalom D; Rantanen J; Genina N
Eur J Pharm Biopharm; 2019 Mar; 136():38-47. PubMed ID: 30630061
[TBL] [Abstract][Full Text] [Related]
12. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Inkjet-Printed Pharmaceuticals on Porous Substrates Using Raman Spectroscopy and Near-Infrared Spectroscopy.
Edinger M; Iftimi LD; Markl D; Al-Sharabi M; Bar-Shalom D; Rantanen J; Genina N
AAPS PharmSciTech; 2019 Jun; 20(5):207. PubMed ID: 31161397
[TBL] [Abstract][Full Text] [Related]
14. A step toward development of printable dosage forms for poorly soluble drugs.
Raijada D; Genina N; Fors D; Wisaeus E; Peltonen J; Rantanen J; Sandler N
J Pharm Sci; 2013 Oct; 102(10):3694-704. PubMed ID: 23904182
[TBL] [Abstract][Full Text] [Related]
15. Inkjet printing of layer-by-layer assembled poly(lactide) stereocomplex with encapsulated proteins.
Akagi T; Fujiwara T; Akashi M
Langmuir; 2014 Feb; 30(6):1669-76. PubMed ID: 24460124
[TBL] [Abstract][Full Text] [Related]
16. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
[TBL] [Abstract][Full Text] [Related]
17. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.
Linares V; Casas M; Caraballo I
Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539
[TBL] [Abstract][Full Text] [Related]
18. Printing of polymer microcapsules for enzyme immobilization on paper substrate.
Savolainen A; Zhang Y; Rochefort D; Holopainen U; Erho T; Virtanen J; Smolander M
Biomacromolecules; 2011 Jun; 12(6):2008-15. PubMed ID: 21568314
[TBL] [Abstract][Full Text] [Related]
19. Analytical aspects of printed oral dosage forms.
Edinger M; Jacobsen J; Bar-Shalom D; Rantanen J; Genina N
Int J Pharm; 2018 Dec; 553(1-2):97-108. PubMed ID: 30316794
[TBL] [Abstract][Full Text] [Related]
20. Performance and penetration of laccase and ABTS inks on various printing substrates.
Matilainen K; Hämäläinen T; Savolainen A; Sipiläinen-Malm T; Peltonen J; Erho T; Smolander M
Colloids Surf B Biointerfaces; 2012 Feb; 90():119-28. PubMed ID: 22051108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
